devices and electronics
patents
+11

Sep 14, 2026
•
5 min read
From tumors put on a starvation diet to wristbands that read intent before the hand moves, to smelter exhaust turned into baseline power — here are the patent moves shaping market caps.
patents
+10

Sep 7, 2026
•
7 min read
Six IP moves, each labeled granted, allowed, or still pending: AIM's Keytruda combination patent issues, Oryzon's AML claims win allowance, Cree LED settles a fifth LED dispute, Lightbridge banks a DOE slot and a Japanese allowance, NewHydrogen files a provisional, and Quantum Cyber's EMP filament stays unverified.
patents
+7

Aug 31, 2026
•
7 min read
Last week's biggest IP moves: SpineGuard drills without X-rays, Incuvate sues Penumbra over five patents mid-acquisition, and SalesCloser stops AI reps from forgetting the conversation.
patents
+5

Aug 10, 2026
•
5 min read
From open-air medical wands to wireless EV charging and a Federal Circuit win over Apple—see the high-stakes IP assets moving stock tickers this week. 🚀

patents
+3

Aug 3, 2026
•
5 min read
From 20-year drug moats to GPS-proof drone swarms and AI blueprints, see the high-stakes IP moves driving markets this week.
patents
+3

Jul 27, 2026
•
5 min read
From 10-minute knee rebuilds to trip-free PTSD therapies, here are the market-shifting patents moving stock tickers this week.
patents
+3

Jul 20, 2026
•
5 min read
Boostimmune strips cancer's bodyguards 🛡️, Unanimous AI builds a real-time human hive mind 🎥, and Smart Plastic feeds polymers to soil microbes 🦠

patents
+3

Jul 13, 2026
•
5 min read
Barrel Proof RF-scans whiskey barrels 🥃, Nuclear Diamond builds a forever battery 🔋, and LG Chem wins a landmark OLED patent fight 📺.
patents
+3

Jul 6, 2026
•
5 min read
Anixa guards its cancer recipe 🛡️, Provectus hunts superbugs in the dark 🕶️, and Equifax vaporizes identity thieves 🛑.